News & Views
Synthesising Gold Nanoparticles: Is this the way forward for non-invasive cancer therapy?
Jul 20 2021
Using a biomolecule called B3 peptide, scientists at the Tokyo Institute of Technology (Tokyo Tech) have designed an eco-friendly protocol for synthesising gold nanoparticles with optimised morphology for near-infrared light absorption. The paper  describes the synthesis of triangular and circular gold nanoplates and their effectiveness in killing cancer cells by converting the absorbed light into heat, providing useful insights for the development of non-invasive cancer therapy.
“Because NIR light is able to penetrate biological tissues, it can illuminate the gold nanoparticles within the body and turn them into nano-sized cell heating agents,” explained Professor Masayoshi Tanaka from Tokyo Tech who researches nanomaterials for biomedical applications.
Gold nanoplates (AuNPls) are extremely efficient in their absorption of NIR light which makes them highly attractive photothermal therapeutic agents. However, synthesising these nanoparticles requires harsh reagents and highly toxic conditions, making the process hazardous. In the most recent study, Professor Tanaka and his collaborators from UK (University of Leeds) and Korea (Chung-Ang University) have now addressed this issue by developing a safer and more eco-friendly protocol for AuNPl synthesis, the results of which are published in ACTA Biomaterialia.
The team employed a process called ‘biomineralization’ that uses biomolecules to generate metal nanoparticles with tunable structures. “Peptides, or short chains of amino acids, are particularly attractive candidates for this purpose because of their relatively small size and stability. However, their use for producing Au nanoparticles with optimised structures for efficient NIR absorption has not yet been reported,” said Professor Tanaka.
The team began by identifying peptides suitable for the mineralisation of AuNPls and, after picking out over 100 peptides, decided to examine the potential of a peptide named B3 for synthesising AuNPls with controllable structure that can serve as photothermal conversion agents.
In a process called ‘one pot synthesis’, the team mixed a gold salt, HAuCl4, along with B3 peptide and its derivatives at various concentrations in a buffer solution (an aqueous solution resistant to changes in pH) at neutral pH and synthesised triangular and circular-shaped AuNPls with different levels of NIR absorption based on the peptide concentration.
The team then tested the effect of the AuNPls on cultured cancer cells under irradiated conditions and found them to exhibit the desired therapeutic effects. Furthermore, on characterising the peptide using B3 derivatives, they found that an amino acid called histidine governed the structure of the AuNPls.
“These findings provide not only an easy and green synthetic method for AuNPls but also insight into the regulation of peptide-based nanoparticle synthesis,” commented Professor Tanaka excitedly. “This could open doors to new techniques for non-toxic synthesis of nanoparticle therapeutic agents.”
1. Synthesis of near-infrared absorbing triangular Au nanoplates using biomineralisation peptides was first published in the journal ACTA Biomaterialia.
Authors: Masayoshi Tanaka1, Mirei Hayashi1, Lucien Roach2, Yuka Kiriki1, Tetsuya Kadonosono3, Takahiro Nomoto4, Nobuhiro Nishiyama4, Jonghoon Choi5, Kevin Critchley2, Stephen D. Evans2 and Mina Okochi1
1Department of Chemical Science and Engineering, Tokyo Institute of Technology
2School of Physics and Astronomy, University of Leeds
3School of Life Science and Technology, Tokyo Institute of Technology
4Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology
5School of Integrative Engineering, Chung-Ang University
More information online
In This Edition Articles - The challenges of Biosample access and what needs to change - Innovative UK exports must gather income - not dust Spotlight Life Sciences - How a Pipettin...
View all digital editions
Sep 21 2021 Lagos, Nigeria
Sep 27 2021 Virtual event
Sep 27 2021 Beijing, China
Sep 28 2021 Glasgow, Scotland
Sep 29 2021 Online event